Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Mixed Digital Maturity in GMP: Lessons from a Multi-Site Pharma Transformation

A pharmaceutical manufacturing site approached Zamann Pharma Support to understand the hidden risks created by different levels of digital maturity across production areas.

Although both production areas operated under the same site quality framework, their daily processes followed completely different realities. One production area used modern digital systems, including electronic batch records (eBR), automated data capture, and system-based workflows. Meanwhile, another production area still relied heavily on paper documentation, manual calculations, and later data transfers.

As a result, experienced QA specialists and deviation owners faced unexpected challenges when supporting different areas. Processes that looked identical on paper required completely different approaches in practice.

Therefore, the company needed a structured assessment to identify process gaps, understand operational risks, and define a practical roadmap for harmonizing digital and paper-based workflows.

Our Team analyzed the client’s mixed digital maturity environment, identified operational gaps, and provided a structured approach to harmonize processes across different production areas.

The project helped the company understand hidden complexity, improve process alignment, and establish a clear foundation for future digital transformation.

Challenges Faced

A detailed GAP analysis in Quality Management Systems is essential for identifying process deficiencies effectively.
  • Different Digital Maturity Levels Across One Manufacturing Site: The client managed areas with different digital maturity levels, combining automated systems with paper-based workflows.
  • Inconsistent Documentation and Data Handling Processes: Although SOPs were identical, data handling differed between digital and manual processes.
  • Increased Complexity for QA and Deviation Management: QA teams faced challenges adapting to different workflows and investigation methods.
  • Hidden Operational Costs Behind Similar KPIs: Similar KPIs hid the impact of lower digital maturity, including extra reviews and manual risks.

Zamann Pharma Support’s Approach

  • Process Reality Assessment Across Production Areas: Zamann Pharma Support assessed daily workflows across production areas to identify gaps between documented processes and actual operations.
  • Mapping Digital and Paper-Based Workflows: The team compared both environments to understand differences in systems, documentation, controls, and process execution.
  • Identification of Digital Control Opportunities: Zamann analyzed how eBR and LIMS supported data management, workflow control, and deviation handling to identify improvement opportunities.
  • Development of a Harmonization Roadmap: The assessment defined a practical roadmap to standardize processes, improve consistency, and support future digitalization.
  • Alignment of Process Maturity with Management Decisions: Zamann helped leadership understand the impact of digital maturity differences and prioritize improvement areas.

Results Achieved

  • Improved Understanding of Digital Maturity Risks: The assessment helped the organization understand how digital gaps affected operations, quality activities, and collaboration.
  • Better Alignment Between Production Areas: By comparing workflows, the company identified process differences and opportunities for harmonization.
  • Reduced Complexity in QA and Investigation Activities: The organization gained clearer insight into how manual processes increased investigation effort and complexity.
  • Stronger Foundation for Future Digitalization: The digital area provided a practical model to improve less mature processes and support future transformation.
Laboratory
Digital GMP software systems with audit trail monitoring, lifecycle validation controls, and risk-based data governance supporting inspection readiness.
Services

Digital Solutions for GMP Operations

We support pharmaceutical teams in implementing, maintaining, and optimizing GMP software, data management systems, and computerized workflows that strengthen compliance, data integrity, and operational efficiency.

Read More

Contact Us

Need help? Don't hesitate to get in touch
Zamann pharma support is committed to protecting and respecting your privacy, and we’ll use your personal information to administer your account and to provide the products and services you requested from us.

FAQ

1.How do mixed digital maturity levels affect GMP compliance in pharmaceutical manufacturing?

Different digital maturity levels can create inconsistent process controls, documentation practices, and data handling methods across production areas. These differences may increase risks related to data integrity, investigations, and quality decisions.

2. Why can the same GMP SOP create different operational risks across production areas?

A single SOP may define the same requirements, but implementation can vary depending on available systems and workflows. Digital areas may use automated controls, while paper-based areas may depend on manual records and calculations.

3. How can pharmaceutical sites harmonize digital and paper-based GMP processes?

Sites can compare workflows, identify digital control advantages, standardize critical process steps, and create structured improvement roadmaps to reduce differences between production environments.